The alternative health industry is widely broadcasting that so-called dangerous genetic variation is lurking in the human population, causing a public health crisis that is ignored by the medical ...
LONDON (MarketWatch) -- Strategene Corp. posted first-quarter net income that rose to $2.9 million, or 13 cents a share, from $2.1 million, or 13 cents a share, in the year earlier quarter. Revenue ...